| Return on average equity - 5 year average | 4.12 |
| Net Income/employee - trailing 12 month | 0.00 |
| Revenue/employee - most recent fiscal year | 0.00 |
| Return on investment - most recent fiscal year | 0.25 |
| Return on average assets - most recent fiscal year | 0.20 |
| Receivables turnover - most recent fiscal year | 2.27 |
| Return on investment - trailing 12 month | 4.04 |
| Return on average assets - trailing 12 month | 3.54 |
| Inventory turnover - most recent fiscal year | 4.90 |
| Inventory turnover - trailing 12 month | 21.54 |
| Revenue/employee - trailing 12 month | 0.00 |
| Return on average assets - 5 year average | 2.81 |
| Net Income/employee - most recent fiscal year | 0.00 |
| Return on average equity - trailing 12 month | 4.04 |
| Receivables turnover - trailing 12 month | 12.09 |
| Asset turnover - most recent fiscal year | 0.27 |
| Asset turnover - trailing 12 month | 0.75 |
| Return on average equity - most recent fiscal year | 0.25 |
| Return on investment - 5 year average | 4.12 |
EVOQ Remedies Dividend EVOQ Remedies Bonus EVOQ Remedies News EVOQ Remedies AGM EVOQ Remedies Rights EVOQ Remedies Splits EVOQ Remedies Board Meetings EVOQ Remedies Shareholdings EVOQ Remedies Profit Loss EVOQ Remedies Balance Sheet EVOQ Remedies Cashflow EVOQ Remedies Q1 Results EVOQ Remedies Q2 Results EVOQ Remedies Q3 Results EVOQ Remedies Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks